The Metabolic Bone Disease X-linked Hypophosphatemia: Case Presentation, Pathophysiology and Pharmacology

The authors present a stereotypical case presentation of X-linked hypophosphatemia (XLH) and provide a review of the pathophysiology and related pharmacology of this condition, primarily focusing on the FDA-approved medication burosumab. XLH is a renal phosphate wasting disorder caused by loss of fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincze, Jon, Skinner, Brian W., Tucker, Katherine A., Conaway, Kory A., Lowery, Jonathan W., Hum, Julia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232744/
https://www.ncbi.nlm.nih.gov/pubmed/34203792
http://dx.doi.org/10.3390/life11060563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232744/
https://www.ncbi.nlm.nih.gov/pubmed/34203792
http://dx.doi.org/10.3390/life11060563

Ejemplares similares